Gefitinib is a drug practiced for several breast, lung, and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which prevents signaling through the epidermal cancer factor receptor in target cells.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Save my name, email, and website in this browser for the next time I comment.